Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1993
10/14/1993CA2132445A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
10/14/1993CA2132342A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
10/14/1993CA2132341A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993CA2132340A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivatives conjugates and labels
10/14/1993CA2132339A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels
10/14/1993CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993CA2117884A1 Non-infectious hiv particles and uses therefor
10/13/1993EP0565236A2 Colour-coded inactivated vaccines for poultry
10/13/1993EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment
10/13/1993EP0565164A1 Synthetic polypeptides as inhibitors of HIV-1
10/13/1993EP0564786A2 Method for processing and preserving collagen-based tissues for transplantation
10/13/1993EP0564689A1 Recombinant live vaccines against Gram-negative enteric pathogens
10/13/1993EP0564620A1 Dermatomycosis vaccine
10/13/1993EP0564592A1 Liver enriched transcription factor
10/13/1993EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus
10/13/1993EP0564477A1 Fragments of the env protein of the feline immunodeficiency virus, antibodies and their applications in diagnosis
10/13/1993CN1077132A Hepatitis A attenuated live vaccine and preparing method thereof
10/12/1993US5252711 Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
10/12/1993US5252480 Human monoclonal antibody and hybridoma producing the same
10/12/1993US5252467 Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE
10/12/1993US5252328 Veterinary medicine
10/12/1993US5252327 Solutions containing antigen and zinc hydroxide or iron hydroxide as an adjuvant and processes for preparing such solutions
10/12/1993US5252289 Water soluble 1,2-dithio-3-thiones
10/06/1993EP0563797A1 Pyridinium derivatives
10/06/1993EP0563627A2 Anti-tumor method and anti-tumor agent
10/06/1993EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
10/06/1993EP0563485A1 In vitro generation of human dendritic cells and uses thereof
10/06/1993EP0563475A1 Cell binding agent conjugates of derivatives of CC-1065
10/06/1993EP0563323A1 Hiv reverse transcriptase vaccine
10/06/1993EP0563311A1 Improved vaccines
10/06/1993EP0563307A1 Medicaments for the treatment of papillomavirus diseases
10/06/1993EP0563304A1 Neuronal cholinergic differentiation factor
10/06/1993EP0563288A1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
10/06/1993EP0563240A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/06/1993EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS
10/06/1993EP0563093A1 A composition used as a therapeutic agent against chronic viral hepatic diseases
10/06/1993EP0563091A1 Vaccines based on hepatitis b surface antigen
10/06/1993EP0379516B1 Hyper-immune globulin against hiv
10/06/1993CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4
10/06/1993CN1076865A A novel process for preparing a vaccine for hemorrhagic fever with renal syndrome
10/06/1993CN1022331C Hepatitis A attenuation living vaccine (H2 attenuation strains) and prepn. thereof
10/05/1993US5250519 Non-anticoagulant heparin derivatives
10/05/1993US5250298 Live attenuated newcastle disease virus vaccines and preparation thereof
10/05/1993US5250296 Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
10/05/1993CA1322721C Vaccine and method of preparation
10/02/1993WO1993020105A1 Complexes of the peptidoglycan monomer (pgm) with trivalent metals, process for the manufacture thereof and their use
10/02/1993CA2133087A1 Complexes of the peptidoglycan monomer (pgm) with trivalent metals, process for the manufacture thereof and their use
10/02/1993CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
09/1993
09/30/1993WO1993019373A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
09/30/1993WO1993019196A1 ANTI-CD3 AGLYCOSYLATED IgG ANTIBODY
09/30/1993WO1993019183A1 Immunization by inoculatioon of dna transcription unit
09/30/1993WO1993019180A1 Genetically engineered antibodies
09/30/1993WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993WO1993019178A2 Peptides useful for inducing tolerance
09/30/1993WO1993019162A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality
09/30/1993WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
09/30/1993WO1993019093A1 Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of mycobacterium tuberculosis complex living bacteria, and applications
09/30/1993WO1993019092A1 Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins
09/30/1993WO1993019090A1 High molecular weight surface proteines of non-typeable haemophilus
09/30/1993WO1993019085A1 Novel antler-derived bone growth factors
09/30/1993WO1993018792A1 Selective alteration of antibody immunogenicity
09/30/1993WO1993018791A1 Vaccine for preventing hiv-infected disease and production thereof
09/30/1993WO1993018790A1 Vaccine containing live virus for therapy of viral diseases and malignancies
09/30/1993WO1993018789A1 Non-azo naphthalimide dyes and uses for same
09/30/1993WO1993018787A1 Trans-sialidase and methods of use and making thereof
09/30/1993WO1993018782A1 Glycosylation-mediated inhibition of factor x
09/30/1993WO1993018750A1 Method for reducing side-effects of a drug
09/30/1993WO1993016185A3 Biosynthetic binding protein for cancer marker
09/30/1993WO1993016099A3 Dna sequences encoding novel growth/differentiation factors
09/30/1993WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
09/30/1993WO1992001049A3 Cd53 cell surface antigen and use thereof
09/30/1993CA2132518A1 Glycosylation-mediated inhibition of factor x
09/30/1993CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993CA2132219A1 Novel antler-derived bone growth factors
09/30/1993CA2132218A1 Peptide sequence capable of inducing a dalayed-type hypersensitivity reaction in the presence of mycobacterium tuberculosis complex living bacteria, and applications
09/30/1993CA2131790A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality
09/30/1993CA2131621A1 Selective alteration of antibody immunogenicity
09/30/1993CA2130173A1 Genetically engineered antibodies
09/29/1993EP0562853A1 29-Demethoxyrapamycin for inducing immunosuppression
09/29/1993EP0562508A2 Protein with bone formation ability and process for its production
09/29/1993EP0562136A1 Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases
09/29/1993EP0562125A1 Antibody composition
09/29/1993EP0562123A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine
09/29/1993EP0562107A1 Oligoside derived from an antigen polyoside obtained from a pathogenic agent
09/29/1993EP0562020A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
09/29/1993EP0562013A1 Human retrovirus receptor and dna coding therefor
09/29/1993EP0561953A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin
09/29/1993EP0561890A1 Dna expression systems based on alphaviruses
09/29/1993EP0561885A1 Subunit papillomavirus vaccine and peptides for use therein
09/29/1993EP0357709B1 Preservation of viruses
09/29/1993EP0334841B1 Micro-organisms and plasmids for producing 2,4-dichlorophenoxy acetic acid (2,4-d)-monooxygenase and process for producing these plasmids and strains
09/29/1993EP0247091B1 Modular assembly of antibody genes, antibodies prepared thereby and use
09/29/1993EP0185034B1 Inhibin isolated from ovarian follicular fluid
09/29/1993CN1076728A Viral vaccines
09/29/1993CN1076726A Hepatitis A vaccine and its production method
09/28/1993US5248772 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
09/28/1993CA2092768A1 Protein with bone formation ability and process for its production
09/28/1993CA2092729A1 Method for inducing immunosuppression
09/24/1993WO1993019185A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine
09/24/1993CA2132420A1 Recombinant antigen containing in its sequence a heterologous immuno-stimulatory domain-use as a vaccine
1 ... 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 ... 1823